DKS Co., Ltd. (JP:4461)
:4461
4461 Stock Chart & Stats
¥8230.00
-¥60.00(-1.64%)
At close: 4:00 PM EST
¥8230.00
-¥60.00(-1.64%)
Day’s Range― - ―
52-Week Range¥2,107.00 - ¥12,550.00
Previous CloseN/A
Volume29.40K
Average Volume (3M)144.71K
Market Cap
¥83.38B
Enterprise Value¥91.55B
Total Cash (Recent Filing)¥15.44B
Total Debt (Recent Filing)¥29.98B
Price to Earnings (P/E)10.6
Beta1.42
Next Earnings
May 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.24%
Share Statistics
EPS (TTM)198.02
Shares Outstanding10,684,321
10 Day Avg. Volume174,660
30 Day Avg. Volume144,713
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)0.68
Price to Sales (P/S)0.36
P/FCF Ratio4.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)439.4
Revenue Forecast (FY)¥79.00B
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationSustained positive free cash flow in FY2024–FY2025 indicates the company can internally fund operations, maintenance capex, and some strategic investment without relying solely on external financing. Over 2–6 months this supports balance sheet resilience and funds reinvestment or debt reduction, improving earnings quality and strategic optionality.
Profitability Rebound In FY2025A meaningful margin recovery and return to profitability signal restored operational leverage and cost recovery after a loss year. If margins hold, the company can generate stronger free cash flow and improve return metrics, making core earnings more durable and supporting long-term strategic investments and stakeholder confidence.
Diversified Specialty-chemicals PortfolioA broad product mix across electronics, automotive and pharmaceuticals reduces reliance on any single end market and supports steady demand. Specialty chemical positions and a sustainability focus create differentiation, higher switching costs, and opportunities for tailored, higher-margin solutions that sustain revenue over cycles.
Bears Say
Meaningful Leverage RemainsA debt-to-equity level near 0.8x leaves limited financial cushioning and reduces flexibility to pursue large capex or acquisitions without adding leverage. Interest and principal obligations can pressure margins and cash available for strategic initiatives, elevating refinancing and liquidity risk through industry cycles.
Inconsistent Revenue And EarningsUneven top-line performance and historical earnings volatility suggest exposure to cyclical demand or episodic disruptions. This unpredictability complicates multi-year planning, weakens forecasting reliability, and raises execution risk for sustaining investments or dividends when end markets cool.
Free Cash Flow Sensitivity To CyclesIntermittent negative free cash flow in past years shows cash generation is vulnerable to working-capital swings and capex timing. That volatility can impair the company's ability to consistently de-lever, maintain payouts, or invest countercyclically, increasing funding risk in weaker demand periods.
DKS Co., Ltd. News
4461 FAQ
What was DKS Co., Ltd.’s price range in the past 12 months?
DKS Co., Ltd. lowest stock price was ¥2107.00 and its highest was ¥12550.00 in the past 12 months.
What is DKS Co., Ltd.’s market cap?
DKS Co., Ltd.’s market cap is ¥83.38B.
When is DKS Co., Ltd.’s upcoming earnings report date?
DKS Co., Ltd.’s upcoming earnings report date is May 20, 2026 which is in 52 days.
How were DKS Co., Ltd.’s earnings last quarter?
DKS Co., Ltd. released its earnings results on Jan 28, 2026. The company reported ¥198.02 earnings per share for the quarter, beating the consensus estimate of N/A by ¥198.02.
Is DKS Co., Ltd. overvalued?
According to Wall Street analysts DKS Co., Ltd.’s price is currently Overvalued.
Does DKS Co., Ltd. pay dividends?
DKS Co., Ltd. pays a Semiannually dividend of ¥80 which represents an annual dividend yield of 1.24%. See more information on DKS Co., Ltd. dividends here
What is DKS Co., Ltd.’s EPS estimate?
DKS Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does DKS Co., Ltd. have?
DKS Co., Ltd. has 10,684,321 shares outstanding.
What happened to DKS Co., Ltd.’s price movement after its last earnings report?
DKS Co., Ltd. reported an EPS of ¥198.02 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 16.358%.
Which hedge fund is a major shareholder of DKS Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4461
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
DKS Co., Ltd.
DKS Co. Ltd. produces and sells surfactants and other industrial chemicals for various industries in Japan and internationally. It operates through six segments: Surfactants, Amenity Materials, Polyurethane Materials, Functional Materials, Electronic Device Materials, and Life Sciences. The company offers nonionic, anionic, cationic, polymerizable, and amphoteric surfactants, as well as formulated surfactant blends; and amenity materials, including sucrose fatty acid esters, sodium carboxymethyl celluloses, cellulose nanofibers and polymers, polyvinyl pyrrolidone, polyacrylamide and polyacrylate, industrial deodorants, and other products. It also provides polyurethane materials, such as polyether polyol, urethane prepolymer, and urethane systems; functional materials comprising radiation-curable monomers and oligomers, waterborne polyurethanes, flame retardants, and amide-based lubricants; and electronic device materials that include ionic liquids, ion-conductive polymers, and ceramic/metal injection molding materials, as well as conductive pastes for electronics, injection molding pellets, and functional inorganic materials. Further, the company supplies health food products that include an I. Japonica-Bombyx Fungus dietary supplement; and Sudachin, a peel extract powder made from citrus fruit. DKS Co. Ltd was formerly known as Dai-ichi Kogyo Seiyaku Co., Ltd. and changed its name to DKS Co. Ltd. in 2013. The company was founded in 1909 and is headquartered in Kyoto, Japan.
Technical Analysis
T Hasegawa Co
―
Sanyo Chemical Industries
―
Tri Chemical Laboratories Inc.
―
Takasago International Corporation
―
MEC Company Ltd.
―
Options Prices
Currently, No data available
---